Skip to main content
Clinical Trials/IRCT20150630022991N11
IRCT20150630022991N11RecruitingPhase 4

Efficacy of Sertraline on the Symptoms and Quality of Life in Irritable Bowel Syndrome Patients

Babol University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • The presence of ROME III diagnostic criteria for the diagnosis of irritable bowel syndrome
  • Written consent for participation in the study

Exclusion Criteria

  • Age under 18 years
  • Allergy to sertraline
  • The presence of warning signs such as chronic fever, weight loss, gastrointestinal bleeding
  • Pregnancy and breast feeding
  • Use of any drug that affects the bowel function (such as laxatives, anti diarrhea and antibiotics) within one month before entering the study
  • Known cases of lactose intolerance
  • Comorbidity of other serious physical or psychological illnesses, serious suicidal thoughts and substance dependence that affect the treatment of patients and their compliance with the study protocol

Investigators

Similar Trials

Efficacy of Sertraline in Irritable Bowel... | Clinical Trial